08045804946
medisus.pharma007@gmail.com
Change Language
IBYRA 150MG TABS

IBYRA 150MG TABS

7500.0 INR/Number

Product Details:

X

IBYRA 150MG TABS Price And Quantity

  • 1 Number
  • 7500.0 INR/Number

IBYRA 150MG TABS Trade Information

  • Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)
  • 1000 Number Per Week
  • 2 Days
  • Yes
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • All India

Product Description

he Ibyra 150 tablet is a prescription anti-cancer medication containing Olaparib, a targeted drug known as a PARP inhibitor. It is primarily used to treat certain types of ovarian, breast, pancreatic, and prostate cancers that have specific gene mutations (e.g., BRCA mutations). 
Key Uses
Ibyra 150 is used in the management of specific cancers, often as a maintenance therapy after chemotherapy, particularly for cancers with BRCA mutations. This includes advanced epithelial ovarian, fallopian tube, primary peritoneal, HER2-negative metastatic or high-risk early breast, germline BRCA-mutated metastatic pancreatic, and BRCA-mutated metastatic castration-resistant prostate cancers. 
How It Works
The medication works by inhibiting the PARP enzyme, which is involved in DNA repair in cells. Cancer cells with certain genetic defects, such as BRCA mutations, rely heavily on this repair pathway. By blocking PARP, Ibyra 150 prevents these cancer cells from repairing their damaged DNA, leading to cell death and slowing tumor growth, while being less toxic to most healthy cells. 
Administration
Ibyra 150 tablets are taken orally, swallowed whole with water, typically at the same time each day, with or without food. They should not be crushed, chewed, or split. The dosage and treatment duration are determined by a healthcare professional. 
Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicines' category



Back to top